Pathstone Holdings
MIST icon

Pathstone Holdings’s Milestone Pharmaceuticals MIST Stock Holding History

Pathstone Holdings’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.8K Sell
15,500
-1,540
-9% -$2.46K ﹤0.01% 2324
2026
Q1 		$20.3K Sell
17,040
-1,000,000
-98% -$1.75M ﹤0.01% 2206
2025
Q4 		$2.1M Buy
1,017,040
+17,040
+2% +$36.7K 0.01% 1002
2025
Q3 		$2M Buy
+1,000,000
New +$1.76M 0.01% 1029

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Pathstone Holdings's MIST Position: Q2 2026 in Review

Pathstone Holdings reduced its Milestone Pharmaceuticals (MIST) stake by 9% in Q2 2026, selling an estimated $2.46K and leaving 15,500 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2324.

Pathstone Holdings first reported a position in MIST in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.1M in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Pathstone Holdings held 15,500 shares of Milestone Pharmaceuticals worth $20.8K as of Q2 2026.
  • Pathstone Holdings sold 1,540 Milestone Pharmaceuticals shares in Q2 2026, an estimated $2.46K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2324 holding.
  • Pathstone Holdings first reported a position in Milestone Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Pathstone Holdings's Milestone Pharmaceuticals position peaked at $2.1M in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.